InvestorsHub Logo
Followers 13
Posts 823
Boards Moderated 0
Alias Born 05/06/2012

Re: None

Thursday, 12/19/2013 2:28:41 PM

Thursday, December 19, 2013 2:28:41 PM

Post# of 715423
Awesome news that most have missed.
Bristol Myers is reported on Bloomberg and CNBC to
have sold its diabetes "business" to AstraZeneca.
That's the small news. The big news is that BM stated
its intent was to move aggressively into a particular area
of cancer research. You guessed it: immuno-cancer therapy.
They are aggressively looking for acquisitions in that
arena. Hello NWBO! Get us a little good news and watch out!
Exciting possibilities.
Oh, didn't somebody named Feuerstein say in a blog that
immunotherapy was dead and that the world of cancer
research/prevention has moved on from there? Hmmmm!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News